Verition Fund Management

Verition Fund Management’s Nautilus Biotechnolgy NAUT Stock Holding History

Verition Fund Management’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-27,995	Closed	-$59K	–	2535
2022 Q3	$59K	Hold	27,995	–	–	﹤0.01%	2681
2022 Q2	$75K	Buy	27,995 +2,995	+12%	+$11.1K	﹤0.01%	2104
2022 Q1	$109K	Hold	25,000	–	–	﹤0.01%	2422
2021 Q4	$130K	Buy	25,000 +10,000	+67%	+$53.5K	﹤0.01%	2301
2021 Q3	$92K	Hold	15,000	–	–	﹤0.01%	1720
2021 Q2	$152K	Sell	15,000 -36,037	-71%	-$390K	﹤0.01%	1640
2021 Q1	$703K	Buy	51,037 +36,037	+240%	+$499K	0.01%	717
2020 Q4	$163K	Hold	15,000	–	–	﹤0.01%	984
2020 Q3	$161K	Buy	+15,000	New	+$160K	﹤0.01%	960

Other funds holding NAUT

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return

Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return

ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return